Arkolith/Insider Trading/EBS/Form 4

Zoon Kathryn C

DirectorEmergent BioSolutions Inc. (EBS) · full profile →Form 4 · filed Aug 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$63K
Net Open-Market Flow
-$63K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 15, 2025Sell(S)7K$8.87$63K72K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-040670) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML